PTGS2 and bacterial urinary tract infection: We found no differences in tissue burdens between diclofenac-treated and mock-treated WT and THP-KO mice (Supplemental Figure 3), suggesting that enhanced UTI susceptibility in THP-KO mice is independent of COX-2 inflammatory pathways in this model.